Weixinkang
SSE · 603676
Market Cap$3.9B
Revenue$1.2B
Employees763
Listed OnSSE
Ticker603676
CEO / ExecMr. Yong Zhang
HeadquartersLhasa
MarketMainland China
Websitewww.wxkpharma.com
Overview
Tibet Weixinkang Medicine Co., Ltd. engages in the research and development, production, and sale of chemical drugs and their bulk drugs in China. The company offers parenteral nutrition vitamins; electrolyte supplements; intravenous iron, trace, electrolytes, and amino acids supplements; antibiotics; acetylcysteine solution for inhalation; medicine for liver diseases; and other special fields. It also offers injection multivitamins, potassium magnesium aspartate for injection, iron sucrose inje
Data Note
This record combines exchange-directory fields with selected profile enrichment. Treat market data, leadership and financial figures as directional unless verified against company filings, exchange announcements or the issuer's own disclosures.